Non-classical antifolates, 5-(N-phenylpyrrolidin-3-yl)-2,4,6-triaminopyrimidines and 2,4-diamino-6(5H)-oxopyrimidines, synthesis and antitumor studies

被引:11
|
作者
Huang, YL
Lin, CF
Lee, YJ
Li, WW
Chao, TC
Bacherikov, VA
Chen, KT
Chen, CM
Su, TL [1 ]
机构
[1] Acad Sinica, Inst Biomed Sci, Bioorgan Chem Lab, Taipei 115, Taiwan
[2] Taipei Med Univ, Coll Pharm, Dept Med Chem, Taipei, Taiwan
[3] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Therapeut Program, New York, NY 10021 USA
关键词
D O I
10.1016/S0968-0896(02)00238-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of non-classical antifolates, namely 5-(N-phenylpyrrolidin-3-yl)-2,4,6-triaminopyrimidines (25a-i) and 2,4-diamino-(N-phenylpyrrolidin-3-yl)-6(5H)-oxopyrimidines (26a,b,c,f,h,i) was synthesized and evaluated for their in vitro cytotoxicity. Reacting aniline derivatives with 1,4-dibromo-2-butanol gave 1-phenyl-3-pyrrolidinols (19a-i), which were oxidized to pyrrolidin-3-ones (20a-i). The Knoevenagel reaction of 20a-i with malononitrile or ethyl cyanoacetate gave 3-(dicyanomethylene)- (21a-i) and 3-[cyano(ethoxycarbonyl)methylene]-pyrrolidines (22a,b,c,f,h,i), respectively, which were subsequently reduced to the corresponding 3-(dicyano)methyl- or 3-[cyano(ethoxycarbonyl)methyl)]pyrrolidines (23a-i and 24a,b,c,f,h,i, respectively). Condensation of either 23a-i or 24a,b,c,f,h,i with guanidine afforded the target compounds. The cytotoxicity of these compounds was evaluated based on their ability to inhibit various human tumors (human colon adenocarcinoma COLO 205, lung carcinoma H23 and its adriamycin resistant cell line H23/0.3, T-cell leukemia MOLT-4, promyelocytic leukemia HL-60, and T-cell acute lymphocytic leukemia CCRF-CEM) cell growth in culture. These studies revealed that the 2,4,6-triaminopyrimidine derivatives were more cytotoxic than the 2,4-diamino-6(5H)-oxopyrimidine counter parts, in which the latter was inactive in all testing systems. The 2,4,6-triaminopyrimidine derivatives bearing halogen substituent on the phenyl ring (25f,h,i) were cytotoxic in all cultured leukemia cell growth. Among these compounds, 5-(4-fluoro and 4-chlorophenyl)-2,4,6-triaminopyrimidines (25e and 25h, respectively) were more potent than methotrexate (MTX) in inhibiting of H23/0.3 cell growth. These compounds inhibit the folate metabolic pathways as indicated by tritium release from [5-H-3]deoxyuridine in MTX sensitive human fibrosarcoma HT-1080 cells. Dihydrofolate reductase is the major target for 25f,h,i, as shown by leucovorin (LV) rescue of MTX cytotoxicity. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:145 / 157
页数:13
相关论文
共 50 条
  • [1] Synthesis and Antimycobacterial Activity of 5-(Hetarylmethylidene)-2,4,6-Pyrimidine-2,4,6(1H,3H,5H )-Triones And 5-(2-Chloropropylidene)-2,4,6-Pyrimidine-2,4,6(1H,3H,5H )-Triones
    Yushin, M. Yu
    Tyrkov, A. G.
    Saroyants, L., V
    Gabitova, N. M.
    Khrapova, A., V
    Genatullina, G. N.
    Ayupova, A. K.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2020, 54 (02) : 134 - 137
  • [2] Synthesis and Antimycobacterial Activity of 5-(Hetarylmethylidene)-2,4,6-Pyrimidine- 2,4,6(1H,3H,5H )-Triones And 5-(2-Chloropropylidene)- 2,4,6-Pyrimidine-2,4,6(1H,3H,5H )-Triones
    M. Yu. Yushin
    A. G. Tyrkov
    L. V. Saroyants
    N. M. Gabitova
    A. V. Khrapova
    G. N. Genatullina
    A. K. Ayupova
    Pharmaceutical Chemistry Journal, 2020, 54 : 134 - 137
  • [3] 5-[(5-Methylthiazol-2-yl)diazenyl]pyrimidine-2,4,6(1H,3H,5H)-trione
    Hokelek, Tuncer
    Seferoglu, Zeynel
    Sahin, Ertan
    Ertan, Nermin
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : o1506 - o1508
  • [4] Synthesis and Antimicrobial Activity of 5-(Arylmethylidene)-2,4,6-Pyrimidine-2,4,6(1H,3H,5H)-Triones
    Luzhnova, S. A.
    Tyrkov, A. G.
    Gabitova, N. M.
    Yurtaeva, E. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2018, 52 (06) : 506 - 509
  • [5] Synthesis and Antimicrobial Activity of 5-(Arylmethylidene)-2,4,6-Pyrimidine-2,4,6(1H,3H,5H)-Triones
    S. A. Luzhnova
    A. G. Tyrkov
    N. M. Gabitova
    E. A. Yurtaeva
    Pharmaceutical Chemistry Journal, 2018, 52 : 506 - 509
  • [6] Antituberculotic Activity of 5-Aryl(Hetaryl)-Methylidene- 2,4,6-Pyrimidine-2,4,6(1H,3H,5H)-Triones and 5-(2-Chloropropylidene)-2,4,6-Pyrimidine-2,4,6(1H,3H,5H)-Triones
    M. Yu. Yushin
    A. G. Tyrkov
    A. V. Lutsenko
    L. V. Saroyants
    G. N. Genatullina
    A. K. Ayupova
    Pharmaceutical Chemistry Journal, 2023, 57 : 214 - 217
  • [7] Reaction of 5-(Arylmethylidene)-2,4,6-pyrimidine2,4,6(1H,3H,5H)-triones with Morpholine N-Oxide
    A. G. Tyrkov
    Russian Journal of Organic Chemistry, 2020, 56 : 939 - 941
  • [8] Synthesis of 2,4,6(1H,3H,5H)-pyrimidinetrione-5-carboxaldehyde
    Erkin, A. V.
    Krutikov, V. I.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2010, 80 (03) : 551 - 552
  • [9] Synthesis of 2,4,6(1H,3H,5H)-pyrimidinetrione-5-carboxaldehyde
    A. V. Erkin
    V. I. Krutikov
    Russian Journal of General Chemistry, 2010, 80 : 551 - 552
  • [10] Antituberculotic Activity of 5-Aryl(Hetaryl)-Methylidene-2,4,6-Pyrimidine-2,4,6(1H,3H,5H)-Triones and 5-(2-Chloropropylidene)-2,4,6-Pyrimidine-2,4,6(1H,3H,5H)-Triones
    Yushin, M. Yu.
    Tyrkov, A. G.
    Lutsenko, A. V.
    Saroyants, L. V.
    Genatullina, G. N.
    Ayupova, A. K.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2023, 57 (02) : 214 - 217